Skip to main content
SpringerLink
Log in

High prevalence of resistance to second-line anti-TB drugs

  • Epidemiology clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, et al. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet: [12 pages], 30 Aug 2012. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(12)60734-X

  2. Hoffner S.Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control. Lancet: [2 pages], 30 Aug 2012. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(12)61069-1

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

High prevalence of resistance to second-line anti-TB drugs. React. Wkly. 1418, 4 (2012). https://doi.org/10.2165/00128415-201214180-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214180-00017

Keywords

Search

Navigation